JPMorgan Chase & Co. Increases Position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE)
JPMorgan Chase & Co. increased its position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) by 29.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,094 shares of the company’s stock after acquiring an additional 5,551 shares during the period. JPMorgan […]
JPMorgan Chase & Co. increased its position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) by 29.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,094 shares of the company’s stock after acquiring an additional 5,551 shares during the period. JPMorgan […]
